Getinge – Consensus estimates Q2 2024
Getinge – Consensus estimates Q2 2024
2024-07-15 14:30:00
Estimates compiled by Modular Finance on behalf of Getinge.
Number of contributors: 13 (all of which have been updated or confirmed before the report)
| KPI (MSEK, unless otherwise specified) | Q2 2024E |
| Net sales | 7,941 |
| Organic growth (%) | 4.7 |
| Adjusted EBITA | 829 |
| Adjusted EBITA (%) | 10.4 |
| Adjusted EBIT | 765 |
| Adjusted EBIT (%) | 9.6 |
| Net profit | 442 |
| Earnings per share (SEK) | 1.62 |
| Sales per business area | |
| Acute Care Therapies | 3,909 |
| Life Science | 1,169 |
| Surgical Workflows | 2,881 |
| Adjusted EBITA per business area | |
| Acute Care Therapies | 693 |
| Life Science | 118 |
| Surgical Workflows | 115 |
| Group functions | - 97 |
Getinge’s Q2 report will be released on Thursday, July 18, at 8:00 am CEST.